iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Trading Down 2.5% – Here’s What Happened

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) shares dropped 2.5% on Tuesday . The stock traded as low as $19.88 and last traded at $19.98. Approximately 23,050 shares traded hands during trading, a decline of 23% from the average daily volume of 30,046 shares. The stock had previously closed at $20.49.

iShares Genomics Immunology and Healthcare ETF Stock Performance

The stock’s 50 day moving average is $22.24 and its two-hundred day moving average is $23.28. The stock has a market capitalization of $103.90 million, a PE ratio of 23.45 and a beta of 1.03.

Institutional Trading of iShares Genomics Immunology and Healthcare ETF

An institutional investor recently raised its position in iShares Genomics Immunology and Healthcare ETF stock. Avior Wealth Management LLC grew its holdings in shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) by 180.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 26,650 shares of the company’s stock after purchasing an additional 17,150 shares during the quarter. Avior Wealth Management LLC owned approximately 0.46% of iShares Genomics Immunology and Healthcare ETF worth $603,000 at the end of the most recent quarter.

iShares Genomics Immunology and Healthcare ETF Company Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.